Light therapy—or phototherapy, classically referred to as heliotherapy—consists either of exposure to daylight or some equivalent form of light as a treatment for seasonal affective disorder (SAD), or exposure of the skin to specific wavelengths of light using polychromatic polarised light to treat a skin condition.
It is used as a treatment for wintertime seasonal affective disorder and in circadian rhythm disorders, such as delayed sleep phase disorder. There is tentative evidence to support its use to treat non-seasonal psychiatric disorders, in particular major depression and depression in bipolar disorder.
Light therapy treatments for the skin usually involve exposure to ultraviolet light. The exposures can be to a small area of the skin or over the whole body surface, as in a tanning bed. The most common treatment is with narrowband UVB, which has a wavelength of approximately 311–313 nanometers. Exposure to photons (light) at these specific wavelengths enables the body to produce vitamin D. Full body phototherapy can be delivered at a doctor's office or at home using a large high-power UVB booth. Tanning beds, however, generate mostly UVA light, and only 4% to 10% of tanning bed light is in the UVB spectrum.
Light therapy is considered one of the best monotherapy treatments for atopic dermatitis (AD) when applied to patients who have not responded to traditional topical treatments. The therapy offers a wide range of options: UVA1 for acute AD, NB-UVB for chronic AD, and balneophototherapy have proven their efficacy. Patients tolerate the therapy safely but, as in any therapy, there are potential adverse effects and care must be taken in its application, particularly to children.
For psoriasis, UVB phototherapy has been shown to be effective. A feature of psoriasis is localized inflammation mediated by the immune system. Ultraviolet radiation is known to suppress the immune system and reduce inflammatory responses. Light therapy for skin conditions like psoriasis usually use 313 nanometer UVB though it may use UVA (315–400 nm wavelength) or a broader spectrum UVB (280–315 nm wavelength). UVA combined with psoralen, a drug taken orally, is known as PUVA treatment. In UVB phototherapy the exposure time is very short, seconds to minutes depending on intensity of lamps and the person's skin pigment and sensitivity.
About 1% of the human population suffers from vitiligo which causes painless distinct light-colored patches of the skin on the face, hands, and legs. Phototherapy is an effective treatment because it forces skin cells to manufacture melanin to protect the body from UV damage. Prescribed treatment is generally 3 times a week in a clinic or daily at home. About 1 month usually results in re-pigmentation in the face and neck, and 2–4 months in the hands and legs. Narrowband UVB is more suitable to the face and neck and PUVA is more effective at the hands and legs.
As of 2012[update] evidence for light therapy and lasers in the treatment of acne vulgaris was not sufficient to recommend them. There is moderate evidence for the efficacy of blue and blue-red light therapies in treating mild acne, but most studies are of low quality. While light therapy appears to provide short-term benefit, there is a lack of long-term outcome data or data in those with severe acne.
According to the American Cancer Society, there is some evidence that ultraviolet light therapy may be effective in helping treat certain kinds of skin cancer, and ultraviolet blood irradiation therapy is established for this application. However, alternative uses of light for cancer treatment – light box therapy and colored light therapy – are not supported by evidence. Photodynamic therapy (often with red light) is used to treat certain superficial non-melanoma skin cancers.
Other skin conditions
Some types of phototherapy may be effective in the treatment of polymorphous light eruption, cutaneous T-cell lymphoma and lichen planus. Narrowband UVB between 311–313 nanometers is the most common treatment.
Low level laser therapy has been studied as a potential treatment for chronic wounds, and higher-power lasers have sometimes been successfully used to close acute wounds as an alternative to stitching. However, as of 2012[update] and due to inconsistent results and the low quality of extant research, reviews in the scientific literature have not supported its widespread application.
Seasonal affective disorder
The effectiveness of light therapy for treating seasonal affective disorder (SAD) may be linked to the fact that light therapy makes up for lost sunlight exposure and resets the body's internal clock. Studies show that light therapy helps reduce the debilitating and depressive behaviors of SAD, such as excessive sleepiness and fatigue, with results lasting for at least 1 month. Light therapy is preferred over antidepressants in the treatment of SAD because it is a relatively safe and easy therapy.
It is possible that response to light therapy for SAD could be season dependent. Morning therapy has provided the best results because light in the early morning aids in regulating the circadian rhythm. People affected by SAD have low levels of energy and have difficulty concentrating. They usually have a change in appetite and experience trouble sleeping.
A 2007 systematic review by the Swedish agency SBU found insufficient evidence that light therapy was able to alleviate symptoms of depression or seasonal affective disorder. The report recommended that: "Approximately 100 participants are required to establish whether the therapy is moderately more effective than placebo". Although treatment in light therapy rooms was well established in Sweden, no satisfactory, controlled studies had been published on the subject. This led to the closure of a number of clinics offering light therapy in Sweden.
A Cochrane review conducted in 2019 states the evidence that light therapy's effectiveness as a treatment for the prevention of seasonal affective disorder is limited, although the risk of adverse effects are minimal. Therefore, the decision to use light therapy should be based on a person's preference of treatment.
Light therapy has also been suggested in the treatment of non-seasonal depression and other psychiatric mood disturbances, including major depressive disorder, bipolar disorder and postpartum depression. A meta-analysis by the Cochrane Collaboration concluded that "for patients suffering from non-seasonal depression, light therapy offers modest though promising antidepressive efficacy." A 2008 systematic review concluded that "overall, bright light therapy is an excellent candidate for inclusion into the therapeutic inventory available for the treatment of nonseasonal depression today, as adjuvant therapy to antidepressant medication, or eventually as stand-alone treatment for specific subgroups of depressed patients." A 2015 review found that supporting evidence for light therapy was limited due to serious methodological flaws.
A 2016 meta-analysis showed that bright light therapy appeared to be efficacious, particularly when administered for 2-5 weeks' duration and as monotherapy.
Chronic circadian rhythm sleep disorders (CRSD)
In the management of circadian rhythm disorders such as delayed sleep phase disorder (DSPD), the timing of light exposure is critical. Light exposure administered to the eyes before or after the nadir of the core body temperature rhythm can affect the phase response curve. Use upon awakening may also be effective for non-24-hour sleep–wake disorder. Some users have reported success with lights that turn on shortly before awakening (dawn simulation). Evening use is recommended for people with advanced sleep phase disorder. Some, but not all, totally blind people whose retinae are intact, may benefit from light therapy.
Sleep disorder in Parkinson's disease
Sleep disorder in Alzheimer's disease
Studies have shown that daytime and evening light therapy for nursing home patients with Alzheimer’s disease, who often struggle with agitation and fragmented wake/rest cycles effectively led to more consolidated sleep and an increase in circadian rhythm stability.
Neonatal jaundice (Postnatal Jaundice)
Light therapy is used to treat cases of neonatal jaundice. Bilirubin, a yellow pigment normally formed in the liver during the breakdown of old red blood cells, cannot always be effectively cleared by a neonate’s liver causing neonatal jaundice. Accumulation of excess bilirubin can cause central nervous system damage, and so this buildup of bilirubin must be treated. Phototherapy uses the energy from light to isomerize the bilirubin and consequently transform it into compounds that the newborn can excrete via urine and stools. Bilirubin is most successful absorbing light in the blue region of the visible light spectrum, which falls between 460-490 nm. Therefore light therapy technologies that utilize these blue wavelengths are the most successful at isomerizing bilirubin.
Photodynamic therapy is a form of phototherapy using nontoxic light-sensitive compounds that are exposed selectively to light, whereupon they become toxic to targeted malignant and other diseased cells.
The production of the hormone melatonin, a sleep regulator, is inhibited by light and permitted by darkness as registered by photosensitive ganglion cells in the retina. To some degree, the reverse is true for serotonin, which has been linked to mood disorders. Hence, for the purpose of manipulating melatonin levels or timing, light boxes providing very specific types of artificial illumination to the retina of the eye are effective.
Light therapy uses either a light box which emits up to 10,000 lux of light at a specified distance, much brighter than a customary lamp, or a lower intensity of specific wavelengths of light from the blue (460 nm) to the green (525 nm) areas of the visible spectrum. A 1995 study showed that green light therapy at doses of 350 lux produces melatonin suppression and phase shifts equivalent to 10,000 lux white light therapy, but another study published in May 2010 suggests that the blue light often used for SAD treatment should perhaps be replaced by green or white illumination, because of a possible involvement of the cones in melatonin suppression.
Risks and complications
Ultraviolet light causes progressive damage to human skin and erythema even from small doses. This is mediated by genetic damage, collagen damage, as well as destruction of vitamin A and vitamin C in the skin and free radical generation. Ultraviolet light is also known to be a factor in formation of cataracts. Ultraviolet radiation exposure is strongly linked to incidence of skin cancer.
Optical radiation of any kind with enough intensity can cause damage to the eyes and skin including photoconjunctivitis and photokeratitis. Researchers have questioned whether limiting blue light exposure could reduce the risk of age-related macular degeneration. According to the American Academy of Ophthalmology, there is no scientific evidence showing that exposure to blue light emitting devices result in eye damage. According to Harriet Hall, blue light exposure is reported to suppress the production of melatonin, which affects our body's circadian rhythm and can decrease sleep quality. It is reported that bright light therapy may activate the production of reproductive hormones, such as testosterone, luteinizing hormone, follicle-stimulating hormone, and estradiol.
Modern phototherapy lamps used in the treatment of seasonal affective disorder and sleep disorders either filter out or do not emit ultraviolet light and are considered safe and effective for the intended purpose, as long as photosensitizing drugs are not being taken at the same time and in the absence of any existing eye conditions. Light therapy is a mood altering treatment, and just as with drug treatments, there is a possibility of triggering a manic state from a depressive state, causing anxiety and other side effects. While these side effects are usually controllable, it is recommended that patients undertake light therapy under the supervision of an experienced clinician, rather than attempting to self-medicate.
Contraindications to light therapy for seasonal affective disorder include conditions that might render the eyes more vulnerable to phototoxicity, tendency toward mania, photosensitive skin conditions, or use of a photosensitizing herb (such as St. John's wort) or medication. Patients with porphyria should avoid most forms of light therapy. Patients on certain drugs such as methotrexate or chloroquine should use caution with light therapy as there is a chance that these drugs could cause porphyria.
Side effects of light therapy for sleep phase disorders include jumpiness or jitteriness, headache, eye irritation and nausea. Some non-depressive physical complaints, such as poor vision and skin rash or irritation, may improve with light therapy.
Many ancient cultures practiced various forms of heliotherapy, including people of Ancient Greece, Ancient Egypt, and Ancient Rome. The Inca, Assyrian and early German settlers also worshipped the sun as a health bringing deity. Indian medical literature dating to 1500 BCE describes a treatment combining herbs with natural sunlight to treat non-pigmented skin areas. Buddhist literature from about 200 CE and 10th-century Chinese documents make similar references.
The Faroese physician Niels Finsen is believed to be the father of modern phototherapy. He developed the first artificial light source for this purpose. Finsen used short wavelength light to treat lupus vulgaris, a skin infection caused by Mycobacterium tuberculosis. He thought that the beneficial effect was due to ultraviolet light killing the bacteria, but recent studies showed that his lens and filter system did not allow such short wavelengths to pass through, leading instead to the conclusion that light of approximately 400 nanometers generated reactive oxygen that would kill the bacteria. Finsen also used red light to treat smallpox lesions. He received the Nobel Prize in Physiology or Medicine in 1903. Scientific evidence for some of his treatments is lacking, and later eradication of smallpox and development of antibiotics for tuberculosis rendered light therapy obsolete for these diseases.
From the late nineteenth century until the early 1930s, light therapy was considered an effective and mainstream medical therapy in the UK for conditions such as varicose ulcer, 'sickly children' and a wide range of other conditions. Controlled trials by the medical scientist Dora Colebrook, supported by the Medical Research Council, indicated that light therapy was not effective for such a wide range of conditions.
- Blood irradiation therapy
- Free-running sleep
- Low level laser therapy
- Photodynamic therapy
- Sun tanning
- UV-B lamps
- Auger, R. Robert; Burgess, Helen J.; Emens, Jonathan S.; Deriy, Ludmila V.; Thomas, Sherene M.; Sharkey, Katherine M. (2015-10-15). "Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015". Journal of Clinical Sleep Medicine. 11 (10): 1199–1236. doi:10.5664/jcsm.5100. ISSN 1550-9389. PMC 4582061. PMID 26414986.
- Pail, Gerald; Huf, Wolfgang; Pjrek, Edda; Winkler, Dietmar; Willeit, Matthaeus; Praschak-Rieder, Nicole; Kasper, Siegfried (2011). "Bright-light therapy in the treatment of mood disorders". Neuropsychobiology. 64 (3): 152–162. doi:10.1159/000328950. ISSN 1423-0224. PMID 21811085. S2CID 12103204.
- Perera, Stefan; Eisen, Rebecca; Bhatt, Meha; Bhatnagar, Neera; de Souza, Russell; Thabane, Lehana; Samaan, Zainab (2016-03-04). "Light therapy for non-seasonal depression: systematic review and meta-analysis". BJPsych Open. 2 (2): 116–126. doi:10.1192/bjpo.bp.115.001610. ISSN 2056-4724. PMC 4998929. PMID 27703764.
- Meesters, Ybe; Gordijn, Marijke CM (2016-11-30). "Seasonal affective disorder, winter type: current insights and treatment options". Psychology Research and Behavior Management. 9: 317–327. doi:10.2147/PRBM.S114906. ISSN 1179-1578. PMC 5138072. PMID 27942239.
- Sauder, Daniel N. (January 2010). "Light-emitting diodes: their role in skin rejuvenation". International Journal of Dermatology. 49 (1): 12–16. doi:10.1111/j.1365-4632.2009.04246.x. PMID 20465603. S2CID 36549455.
- Grossweiner, Leonard I.; Grossweiner, James B.; Gerald Rogers, B. H. (2005). "Phototherapy of Neonatal Jaundice" (PDF). The Science of Phototherapy: An Introduction. pp. 329–335. doi:10.1007/1-4020-2885-7_13. ISBN 978-1-4020-2883-0.
- Lee E, Koo J, Berger T (2014-01-24). "UVB phototherapy and skin cancer risk: a review of the literature". Int. J. Dermatol. 44 (5): 355–60. doi:10.1111/j.1365-4632.2004.02186.x. PMID 15869531. S2CID 11332443.
- "Treating psoriasis: light therapy and phototherapy – National Psoriasis Foundation". Psoriasis.org. 2014-02-14. Retrieved 2014-02-18.
- Patrizi, A; Raone, B; Ravaioli, GM (5 October 2015). "Management of atopic dermatitis: safety and efficacy of phototherapy". Clinical, Cosmetic and Investigational Dermatology. 8: 511–20. doi:10.2147/CCID.S87987. PMC 4599569. PMID 26491366.
- Diffey BL (1980). "Ultraviolet radiation physics and the skin". Phys. Med. Biol. 25 (3): 405–26. Bibcode:1980PMB....25..405D. doi:10.1088/0031-9155/25/3/001. PMID 6996006.
- "What is Psoriasis: What Causes Psoriasis?". 29 January 2012. Retrieved 11 July 2012.
- Bae, Jung Min; Jung, Han Mi; Hong, Bo Young; Lee, Joo Hee; Choi, Won Joon; Lee, Ji Hae; Kim, Gyong Moon (1 July 2017). "Phototherapy for Vitiligo". JAMA Dermatology. 153 (7): 666–74. doi:10.1001/jamadermatol.2017.0002. PMC 5817459. PMID 28355423.
- Titus S, Hodge J (October 2012). "Diagnosis and treatment of acne". Am Fam Physician. 86 (8): 734–40. PMID 23062156.
- Pei S, Inamadar AC, Adya KA, Tsoukas MM (2015). "Light-based therapies in acne treatment". Indian Dermatol Online J. 6 (3): 145–57. doi:10.4103/2229-5178.156379. PMC 4439741. PMID 26009707.
- Hession MT, Markova A, Graber EM (2015). "A review of hand-held, home-use cosmetic laser and light devices". Dermatol Surg. 41 (3): 307–20. doi:10.1097/DSS.0000000000000283. PMID 25705949. S2CID 39722284.
- Hamilton FL, Car J, Lyons C, Car M, Layton A, Majeed A (June 2009). "Laser and other light therapies for the treatment of acne vulgaris: systematic review". Br. J. Dermatol. 160 (6): 1273–85. doi:10.1111/j.1365-2133.2009.09047.x. PMID 19239470. S2CID 6902995.
- "Light Therapy". American Cancer Society. 14 April 2011. Archived from the original on 2015-02-12. Retrieved 2013-09-08.
- Morton, C.A.; Brown, S.B.; Collins, S.; Ibbotson, S.; Jenkinson, H.; Kurwa, H.; Langmack, K.; Mckenna, K.; Moseley, H.; Pearse, A.D.; Stringer, M.; Taylor, D.K.; Wong, G.; Rhodes, L.E. (April 2002). "Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group". British Journal of Dermatology. 146 (4): 552–567. doi:10.1046/j.1365-2133.2002.04719.x. PMID 11966684. S2CID 7137209.
- Baron ED, Stevens SR (2003). "Phototherapy for cutaneous T-cell lymphoma". Dermatologic Therapy. 16 (4): 303–10. doi:10.1111/j.1396-0296.2003.01642.x. PMID 14686973. S2CID 33047908.
- Bandow, Grace D.; Koo, John Y. M. (August 2004). "Narrow-band ultraviolet B radiation: a review of the current literature". International Journal of Dermatology. 43 (8): 555–561. doi:10.1111/j.1365-4632.2004.02032.x. PMID 15304175. S2CID 27388121.
- Bouzari N, Elsaie ML, Nouri K (2012). "Laser and Light for Wound Healing Stimulation". In Nouri K (ed.). Lasers in Dermatology and Medicine. Springer London. pp. 267–75. doi:10.1007/978-0-85729-281-0_20. ISBN 978-0-85729-281-0.
- Posten W, Wrone DA, Dover JS, Arndt KA, Silapunt S, Alam M (2005). "Low-level laser therapy for wound healing: mechanism and efficacy". Dermatol Surg. 31 (3): 334–40. doi:10.1111/j.1524-4725.2005.31086. PMID 15841638. S2CID 129167.
- Arden, G. B.; Sivaprasad, S. (2012-02-03). "The pathogenesis of early retinal changes of diabetic retinopathy". Documenta Ophthalmologica. 124 (1): 15–26. doi:10.1007/s10633-011-9305-y. ISSN 0012-4486. PMID 22302291. S2CID 25514638.
- Sivaprasad S, Arden G (2016). "Spare the rods and spoil the retina: revisited". Eye (Lond) (Review). 30 (2): 189–92. doi:10.1038/eye.2015.254. PMC 4763134. PMID 26656085.
- "Light Therapy – Topic Overview". WebMD. 30 June 2009. Retrieved 11 July 2012.
- Sanassi Lorraine A (2014). "Seasonal affective disorder: Is there light at the end of the tunnel?". Journal of the American Academy of Physician Assistants. 27 (2): 18–22. doi:10.1097/01.jaa.0000442698.03223.f3. PMID 24394440. S2CID 45234549.
- Thompson C, Stinson D, Smith A (September 1990). "Seasonal affective disorder and season-dependent abnormalities of melatonin suppression by light". Lancet. 336 (8717): 703–06. doi:10.1016/0140-6736(90)92202-S. PMID 1975891. S2CID 34280446.
- Doyle, Ashley. "Light Therapy: Does It Work and Can It Help You?". Savvysleeper. Retrieved 19 July 2019.
- "Light Therapy for Depression, and Other Treatment of Seasonal Affective Disorder". www.sbu.se. Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU). 2007-06-13. Retrieved 2017-06-07.
- Crouch, David (2015-01-24). "Swedish school sheds light on dark days of winter". The Guardian. ISSN 0261-3077. Retrieved 2017-06-07.
- Nussbaumer-Streit, Barbara; Forneris, Catherine A.; Morgan, Laura C.; Van Noord, Megan G.; Gaynes, Bradley N.; Greenblatt, Amy; Wipplinger, Jörg; Lux, Linda J.; Winkler, Dietmar; Gartlehner, Gerald (2019). "Light therapy for preventing seasonal affective disorder". Cochrane Database of Systematic Reviews. 3: CD011269. doi:10.1002/14651858.CD011269.pub3. PMC 6422319. PMID 30883670.
- Benedetti, Francesco; Colombo, Cristina; Pontiggia, Adriana; Bernasconi, Alessandro; Florita, Marcello; Smeraldi, Enrico (June 2003). "Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial". The Journal of Clinical Psychiatry. 64 (6): 648–53. doi:10.4088/JCP.v64n0605. PMID 12823078. S2CID 40483934.
- Tuunainen, Arja; Kripke, Daniel F; Endo, Takuro (2004-04-19). "Light therapy for non‐seasonal depression". The Cochrane Database of Systematic Reviews. 2004 (2): CD004050. doi:10.1002/14651858.CD004050.pub2. ISSN 1469-493X. PMC 6669243. PMID 15106233.
- Prasko J (November 2008). "Bright light therapy". Neuro Endocrinol. Lett. 29 Suppl 1: 33–64. PMID 19029878.
- Terman M (December 2007). "Evolving applications of light therapy". Sleep Med Rev. 11 (6): 497–507. doi:10.1016/j.smrv.2007.06.003. PMID 17964200.
- Tuunainen, Arja; Kripke, Daniel F; Endo, Takuro (19 April 2004). "Light therapy for non-seasonal depression". Cochrane Database of Systematic Reviews (2): CD004050. doi:10.1002/14651858.CD004050.pub2. PMC 6669243. PMID 15106233.
- Even, C; Schröder, CM; Friedman, S; Rouillon, F (2008). "Efficacy of light therapy in nonseasonal depression: A systematic review". Journal of Affective Disorders. 108 (1–2): 11–23. doi:10.1016/j.jad.2007.09.008. PMID 17950467.
- Mårtensson B, Pettersson A, Berglund L, Ekselius L (2015). "Bright white light therapy in depression: A critical review of the evidence". J Affect Disord. 182: 1–7. doi:10.1016/j.jad.2015.04.013. PMID 25942575.CS1 maint: uses authors parameter (link)
- Al-Karawi D, Jubair L. Bright light therapy for nonseasonal depression: Meta-analysis of clinical trials. J Affect Disord. 2016 Jul 1;198:64-71. doi: 10.1016/j.jad.2016.03.016. Epub 2016 Mar 15. PMID: 27011361.
- Bjorvatn, Bjørn; Pallesen, Ståle (February 2009). "A practical approach to circadian rhythm sleep disorders". Sleep Medicine Reviews. 13 (1): 47–60. doi:10.1016/j.smrv.2008.04.009. PMID 18845459.
- Zisapel, Nava (2001). "Circadian Rhythm Sleep Disorders". CNS Drugs. 15 (4): 311–328. doi:10.2165/00023210-200115040-00005. PMID 11463135. S2CID 34990596.
- Dodson, Ehren R.; Zee, Phyllis C (December 2010). "Therapeutics for Circadian Rhythm Sleep Disorders". Sleep Medicine Clinics. 5 (4): 701–715. doi:10.1016/j.jsmc.2010.08.001. ISSN 1556-407X. PMC 3020104. PMID 21243069.
- Brown GM, Pandi-Perumal SR, Trakht I, Cardinali DP (March 2009). "Melatonin and its relevance to jet lag". Travel Med Infect Dis. 7 (2): 69–81. doi:10.1016/j.tmaid.2008.09.004. PMID 19237140.
- Crowley, S.J.; Eastman, C.I. (2013). "Light and Melatonin Treatment for Jet Lag Disorder". Encyclopedia of Sleep. pp. 74–80. doi:10.1016/B978-0-12-378610-4.00285-0. ISBN 978-0-12-378611-1.
- Willis G. L.; Moore C.; Armstrong S. M. (2012). "A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson's disease". Reviews in the Neurosciences. 23 (2): 199–226. doi:10.1515/revneuro-2011-0072. PMID 22499678. S2CID 37717110.
- Satlin, A.; Volicer, L.; Ross, V.; Herz, L.; Campbell, S. (August 1992). "Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease". American Journal of Psychiatry. 149 (8): 1028–1032. doi:10.1176/ajp.149.8.1028. PMID 1353313.
- Ancoli-Israel, Sonia; Gehrman, Philip; Martin, Jennifer L.; Shochat, Tamar; Marler, Matthew; Corey-Bloom, Jody; Levi, Leah (February 2003). "Increased Light Exposure Consolidates Sleep and Strengthens Circadian Rhythms in Severe Alzheimer's Disease Patients". Behavioral Sleep Medicine. 1 (1): 22–36. doi:10.1207/s15402010bsm0101_4. PMID 15600135. S2CID 39597697.
- Hanford, Nicholas; Figueiro, Mariana (21 January 2013). "Light Therapy and Alzheimer's Disease and Related Dementia: Past, Present, and Future". Journal of Alzheimer's Disease. 33 (4): 913–922. doi:10.3233/jad-2012-121645. PMC 3553247. PMID 23099814.
- Newman TB, Kuzniewicz MW, Liljestrand P, Wi S, McCulloch C, Escobar GJ (May 2009). "Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines". Pediatrics. 123 (5): 1352–59. doi:10.1542/peds.2008-1635. PMC 2843697. PMID 19403502.
- "Phototherapy in neonatal jaundice". BMJ. 2 (5805): 62–63. 8 April 1972. doi:10.1136/bmj.2.5805.62-a. S2CID 43085146.
- "Phototherapy for Acne". Aetna.com. Retrieved 2015-02-25.
- Lazzerini Ospri, Lorenzo; Prusky, Glen; Hattar, Samer (25 July 2017). "Mood, the Circadian System, and Melanopsin Retinal Ganglion Cells". Annual Review of Neuroscience. 40 (1): 539–556. doi:10.1146/annurev-neuro-072116-031324. PMC 5654534. PMID 28525301.
- Harrison, S. J.; Tyrer, A. E.; Levitan, R. D.; Xu, X.; Houle, S.; Wilson, A. A.; Nobrega, J. N.; Rusjan, P. M.; Meyer, J. H. (November 2015). "Light therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex". Acta Psychiatrica Scandinavica. 132 (5): 379–388. doi:10.1111/acps.12424. PMC 4942271. PMID 25891484.
- Wu, Mann-Chian; Sung, Huei-Chuan; Lee, Wen-Li; Smith, Graeme D (October 2015). "The effects of light therapy on depression and sleep disruption in older adults in a long-term care facility". International Journal of Nursing Practice. 21 (5): 653–659. doi:10.1111/ijn.12307. PMID 24750268.
- Wright HR, Lack LC, Kennaway DJ (March 2004). "Differential effects of light wavelength in phase advancing the melatonin rhythm". J. Pineal Res. 36 (2): 140–44. doi:10.1046/j.1600-079X.2003.00108.x. PMID 14962066. S2CID 400498.
- Saeeduddin Ahmed; Neil L Cutter; Alfred J. Lewy; Vance K. Bauer; Robert L Sack; Mary S. Cardoza (1995). "Phase Response Curve of Low-Intensity Green Light in Winter Depressives". Sleep Research. 24: 508. doi:10.1186/1471-244X-5-42. PMC 1309618. PMID 16283926.
The magnitude of the phase shifts [using low-level green light therapy] are comparable to those obtained using high-intensity white light in winter-depressives.
- Michel A. Paul; James C. Miller; Gary Gray; Fred Buick; Sofi Blazeski; Josephine Arendt (July 2007). "Circadian Phase Delay Induced by Phototherapeutic Devices". Sleep Research. 78 (7): 645–52.
- J.J. Gooley; S.M.W. Rajaratnam; G.C. Brainard; R.E. Kronauer; C.A. Czeisler; S.W. Lockley (May 2010). "Spectral Responses of the Human Circadian System Depend on the Irradiance and Duration of Exposure to Light". Science Translational Medicine. 2 (31): 31–33. doi:10.1126/scitranslmed.3000741. PMC 4414925. PMID 20463367.
- Matsumura, Yasuhiro; Ananthaswamy, Honnavara N (March 2004). "Toxic effects of ultraviolet radiation on the skin". Toxicology and Applied Pharmacology. 195 (3): 298–308. doi:10.1016/j.taap.2003.08.019. PMID 15020192.
- Barkham (5 June 2012). "One face, but two sides of a story". Theguardian.com. Retrieved 7 October 2014.
- Yam, Jason C. S.; Kwok, Alvin K. H. (31 May 2013). "Ultraviolet light and ocular diseases". International Ophthalmology. 34 (2): 383–400. doi:10.1007/s10792-013-9791-x. PMID 23722672. S2CID 33503388.
- International Commission on Non-Ionizing Radiation, Protection. (August 2004). "Guidelines on limits of exposure to ultraviolet radiation of wavelengths between 180 nm and 400 nm (incoherent optical radiation)". Health Physics. 87 (2): 171–86. doi:10.1097/00004032-200408000-00006. PMID 15257218. S2CID 34605136.
- Ichihashi, M.; Ueda, M.; Budiyanto, A.; Bito, T.; Oka, M.; Fukunaga, M.; Tsuru, K.; Horikawa, T. (July 2003). "UV-induced skin damage". Toxicology. 189 (1–2): 21–39. doi:10.1016/S0300-483X(03)00150-1. PMID 12821280.
- Epstein, Franklin H.; Gilchrest, Barbara A.; Eller, Mark S.; Geller, Alan C.; Yaar, Mina (29 April 1999). "The Pathogenesis of Melanoma Induced by Ultraviolet Radiation". New England Journal of Medicine. 340 (17): 1341–8. doi:10.1056/NEJM199904293401707. PMID 10219070.
- European Commission; Directorate-General for Employment, Social Affairs and Inclusion (2011), Non-binding guide to good practice for implementing Directive 2006/25/EC 'artificial optical radiation', doi:10.2767/74218, ISBN 978-92-79-16046-2
- Glazer-Hockstein C, Dunaief JL (January 2006). "Could blue light-blocking lenses decrease the risk of age-related macular degeneration?". Retina. 26 (1): 1–4. doi:10.1097/00006982-200601000-00001. PMID 16395131. S2CID 29045585.
- American Academy of Ophthalmology. "Should You Be Worried About Blue Light?". American Academy of Ophthalmology. Retrieved 29 December 2020.
- Hall, Harriet (December 2020). "Blue light". Science-based Medicine. Science-based Medicine. Retrieved 29 December 2020.
- "Bright Light May Boost Testosterone". WebMD. Retrieved 2008-12-15.
- Danilenko KV, Samoilova EA (2007). "Stimulatory effect of morning bright light on reproductive hormones and ovulation: results of a controlled crossover trial". PLOS Clinical Trials. 2 (2): e7. doi:10.1371/journal.pctr.0020007. PMC 1851732. PMID 17290302.
- Terman M, Terman JS (August 2005). "Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects". CNS Spectr. 10 (8): 647–63, quiz 672. CiteSeerX 10.1.1.527.6947. doi:10.1017/S1092852900019611. PMID 16041296. S2CID 27002316.
- Gagarina, AK (2007-12-08). "Light Therapy Diagnostic Indications and Contraindications". American Medical Network. Retrieved 2009-06-09.
- Westrin, Åsa; Lam, Raymond W. (October 2007). "Seasonal Affective Disorder: A Clinical Update". Annals of Clinical Psychiatry. 19 (4): 239–246. doi:10.1080/10401230701653476. PMID 18058281.
- Mayo Clinic Staff (20 March 2013). "Light Therapy. Tests and Procedures. Risks". Mayo Clinic. Retrieved 7 February 2014.
- Roger DR (2007-12-04). "Practical aspects of light therapy". American Medical Network. Retrieved 2009-06-09.
- F. Ellinger Medical Radiation Biology Springfield 1957
- Moller, Kirsten Iversen; Kongshoj, Brian; Philipsen, Peter Alshede; Thomsen, Vibeke Ostergaard; Wulf, Hans Christian (2014-11-12). "How Finsen's light cured lupus vulgaris". Photodermatol Photoimmunol Photomed. 21 (3): 118–24. doi:10.1111/j.1600-0781.2005.00159.x. PMID 15888127. S2CID 23272350.
- "The Nobel Prize in Physiology or Medicine 1903". Nobelprize.org. Nobel Media AB. 2016-11-01. Archived from the original on 2016-10-22. Retrieved 2016-11-01.
- "Engines of our Ingenuity No. 1769: NIELS FINSEN". Retrieved 2014-04-05.
- Edwards, Martin (2011). "Dora Colebrook and the evaluation of light therapy". Journal of the Royal Society of Medicine. Royal College of Physicians of Edinburgh and Minervation Ltd. 104 (2): 84–6. doi:10.1258/jrsm.2010.10k067. PMC 3031646. PMID 21282799. Retrieved 12 February 2017.
Natural Light Therapy Significantly accelerates Antidepressants Response. The Canadian Review of Affective Disorder, vol. 5, No 4, Autumn 1995. Khaled Mohamed, M.D.: Gregory Asnis, M.D.
Media related to Phototherapy at Wikimedia Commons